0008

Dezhan Healthcare Company Limited 000813

Market Closed
30 Sep, 06:57
XSHE XSHE
¥
3. 05
+0.27
+9.71%
¥
6.02B Market Cap
- P/E Ratio
0.84% Div Yield
75,831,156 Volume
- Eps
¥ 2.78
Previous Close
Day Range
2.87 3.05
Year Range
2.06 4.46

000813 Chart

Dezhan Healthcare Company Limited Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
- CEO
XSHE Exchange
CNE000000VV8 ISIN
China Country
1,002 Employees
- Last Dividend
24 May 2017 Last Split
- IPO Date

Overview

Dezhan Healthcare Company Limited is a prominent entity in the pharmaceutical industry of the People's Republic of China, focusing on the research and development, manufacturing, and distribution of a wide variety of drugs primarily aimed at treating cardiovascular and cerebrovascular diseases. Since its establishment in 1980, the company has committed itself to producing high-quality medications to meet the health needs of the population and has significantly expanded its product line to include not only pharmaceuticals but also biological peptide products, food and beverages, cosmetics, and other health-related goods. Headquartered in Beijing, Dezhan Healthcare continues to innovate in the healthcare sector, contributing substantially to the local market with its vast array of products and services.

Products and Services

The diverse product range of Dezhan Healthcare encompasses several key areas within the pharmaceutical sector, embodying the company's dedication to heart and brain health, among other specialties. Below is an overview of their prominent offerings:

  • Vastatin Calcium Tablets (Nile): A core product aimed at managing cholesterol levels, vital for patients with cardiovascular conditions.
  • Trimetazidine Hydrochloride Capsules: These capsules are designed to improve myocardial glucose utilization, offering protection against ischemic heart disease.
  • Fanle Type I and II Tablets: Tailored for patients with diabetes, these tablets help in managing blood sugar levels efficiently.
  • Azathioprine Tablets: Primarily used in transplant medicine to prevent organ rejection and in some autoimmune diseases as an immunosuppressant.
  • Amiodarone Hydrochloride Tablets: A critical medication for the treatment of arrhythmias, indicating the company's focus on comprehensive cardiovascular care.
  • Hydroxyurea Tablets: Used in the treatment of certain cancers and sickle cell anemia, showcasing the company's role in catering to a broad spectrum of healthcare needs.
  • Colchicine Tablets: Often prescribed for gout and familial Mediterranean fever, these tablets indicate the company's engagement in addressing less common but impactful health conditions.

In addition to pharmaceuticals, Dezhan Healthcare is actively involved in producing biological peptide products, further emphasizing its focus on innovative healthcare solutions. The company also diversifies its offerings into the food and beverage sector, cosmetics, and other health and wellness products, portraying a holistic approach to healthcare. Each product and service is a testament to Dezhan Healthcare's dedication to improving health outcomes and quality of life for individuals across the People's Republic of China.

Contact Information

Address: Meilin Building, No. 2
Phone: 86 10 6585 8557